Literature DB >> 3295032

Electron microscopic localization of chromogranin A in osmium-fixed neuroendocrine cells with a protein A-gold technique.

S A Hearn.   

Abstract

An antibody (LK2H10) to chromogranin A has been recommended for use in ultrastructural identification of neuroendocrine secretory granules. Previous studies have demonstrated immunoreactive chromogranin A in specimens prepared for electron microscopy by glutaraldehyde fixation only. In this study, the effect of specimen post-fixation by osmium tetroxide on post-embedding localization of chromogranin A was evaluated. Human tissues from benign endocrine glands, neuroendocrine tumors, and non-neuroendocrine tumors were post-fixed in osmium, embedded in epoxy resin, and the sample thin sections immunolabeled using a protein A-gold technique. Chromogranin A-positive neurosecretory granules were detected in pancreatic islets, adrenal medulla, stomach, ileum, anterior pituitary, and parathyroid. Mid-gut carcinoids, bronchial carcinoids, pheochromocytomas, paragangliomas, carotid body tumors, and thyroid medullary carcinomas contained immunoreactive granules. Cytoplasmic granules in non-neuroendocrine tumors did not react for chromogranin A. Tissues post-fixed in osmium tetroxide had optimally preserved ultrastructural features, and use of this fixative is compatible with postembedding localization of chromogranin A in neurosecretory granules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3295032     DOI: 10.1177/35.7.3295032

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  12 in total

Review 1.  Biochemistry of the chromogranin A protein family.

Authors:  J P Simon; D Aunis
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Topology of chromogranins in secretory granules of endocrine cells.

Authors:  Y Cetin; D Grube
Journal:  Histochemistry       Date:  1991

3.  Anaplastic ganglioglioma of the brain stem demonstrating active neurosecretory features of neoplastic neuronal cells.

Authors:  T Hirose; S Kannuki; K Nishida; K Matsumoto; T Sano; K Hizawa
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Topology of chromogranin A and secretogranin II in the rat anterior pituitary: potential marker proteins for distinct secretory pathways in gonadotrophs.

Authors:  T Watanabe; Y Uchiyama; D Grube
Journal:  Histochemistry       Date:  1991

5.  Storage and degradation of secretory proteins in adenomatous and secondary hyperplastic parathyroid cells. An immunoelectron microscope study.

Authors:  G Berger; F Berger; F Billard; J Danowski; J L Vauzelle
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  Co-localization of chromogranin A and B, secretogranin II and neuropeptide Y in chromaffin granules of rat adrenal medulla studied by electron microscopic immunocytochemistry.

Authors:  H J Steiner; K W Schmid; R Fischer-Colbrie; G Sperk; H Winkler
Journal:  Histochemistry       Date:  1989

Review 7.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

8.  Immunocytochemical localization of prohormone convertase 1/3 and 2 in gastrointestinal carcinoids.

Authors:  T Tomita
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

9.  Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.

Authors:  A G Fahrenkamp; C Wibbeke; G Winde; D Ofner; W Böcker; R Fischer-Colbrie; K W Schmid
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Structural and ultrastructural characteristics of human pineal gland, and pineal parenchymal tumors.

Authors:  A Jouvet; M Fèvre-Montange; R Besançon; E Derrington; G Saint-Pierre; M F Belin; J Pialat; C Lapras
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.